Table 3.
Predictive value of clinical factors for protracted decline in ADL: Results of GEE analyses
| POSSUM model | E-PASS model | |||||
| Variables | Odds Ratio | 95% CI | P value | Odds Ratio | 95% CI | P value |
| Surgical Score* | 1.1 | 0.87–1.37 | 0.44 | 1.1 | 0.87–1.31 | 0.51 |
| Age | 1.1 | 0.98–1.25 | 0.09 | 1.1 | 0.97–1.25 | 0.12 |
| Male | 1.3 | 0.60–2.88 | 0.49 | 1.3 | 0.60–2.67 | 0.54 |
| Colon Cancer** | 1.3 | 0.62–2.67 | 0.49 | 1.2 | 0.61–2.45 | 0.56 |
| MMSE | 0.9 | 0.83–0.99 | 0.02 | 0.9 | 0.82–1.01 | 0.08 |
| Pathological Stage | 1.2 | 0.75–1.77 | 0.50 | 1.2 | 0.79–1.82 | 0.39 |
| –2 Log-Likelihood | 215.6 | 215.6 | ||||
* POSSUM and E-PASS CRS scores were included in two separate GEE model calculations
** Colon Cancer/Gastric Cancer